• About
  • Privacy Policy
  • Cookie Policy
  • Terms of Use 
  • My account
  • Contact
Monday, April 27, 2026
  • Login
Arab Health World
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
Arab Health World
No Result
View All Result
  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact
Home Sectors Optometry

AOA makes robust rebuttal to FTC over proposed changes to Eyeglass Rule

MARCH 16, 2023 During the Federal Trade Commission’s (FTC’s) recent comment period on the proposed changes, the AOA recommends updating the Eyeglass Rule to better serve and protect consumers and seeks to meet with agency officials.

admin by admin
March 21, 2023
in Optometry, Sectors
0
0
AOA makes robust rebuttal to FTC over proposed changes to Eyeglass Rule

NY, USA - DECEMBER 16, 2019: Homepage of ftc website on the display of PC, url - ftc.gov.

0
SHARES
270
VIEWS
Share on FacebookShare on Twitter
NY, USA – DECEMBER 16, 2019: Homepage of ftc website on the display of PC, url – ftc.gov.

The AOA is making a strongly considered case to the Federal Trade Commission (FTC) against its proposed changes to the Eyeglass Rule, saying that the proposals don’t reflect real-world marketplace conditions, making signed forms to confirm receipt of prescriptions unnecessary. The FTC’s emphasis is misdirected, the AOA argues.

The arguments were made by the AOA in a letter submitted during the recently ended FTC public comments period for proposed changes to the federal Ophthalmic Practice Rules (also known as the Eyeglass Rule). Among the proposals, the FTC is seeking to require signed acknowledgements from patients confirming they have received copies of their prescriptions following their eye exams. Copies of the acknowledgements would be kept by the practice for at least three years. The change would mirror the burdensome 2021 mandate under the Contact Lens Rule, opposed by the AOA and other medical groups and hundreds of U.S. senators and House members over the course of an epic Washington, D.C., policy clash lasting nearly five years.

Rather than the FTC’s proposed changes, the AOA recommended updating the Eyeglass Rule to better serve and protect consumers, based on its evaluation of consumer complaints and member reporting regarding certain online retailers. The most frequently reported issues, based on those complaints and concerns, relate to vision and fitting challenges and lack of retailer responsiveness following sales. Oftentimes, consumers turn to their local doctors of optometry for help when they experience vision challenges or discomfort after their purchases.

The AOA recommends the Eyeglass Rule update its consumer guidance on buying prescription eyeglasses or contact lenses online to include the following advisory for consumers:

“The online retailer cannot guarantee that the eyeglasses you have purchased will meet your visual needs. The retailer will develop eyeglasses based on the prescription provided. However, errors can occur, and the company is not required to assess whether the eyeglasses have met your visual needs following purchase.”

“If your eyeglasses do not fit well upon receipt, the online retailer is not required to adjust your eyeglasses in person. You will typically be provided with instructions on how best to self-adjust your eyeglasses to address your concerns. Some recommendations may include bending the eyeglasses yourself or adjusting how you hold your head when using the glasses.”

“The online retailer is not obligated to respond to any complaints or issues surrounding your purchase.”

Greater scrutiny is needed of online retailers and mobile apps, said the AOA, noting that none of the FTC’s current guidance addresses purchasing prescription glasses over the internet.

“While significant attention has been paid to how best to ensure physicians are adhering to requirements under the Ophthalmic Practice Act,” AOA President Ronald L. Benner, O.D., said in the AOA’s March 6 comments to the FTC, “we are concerned that online eyeglass retailers are not held to any real quality or ethical standards related to the products they provide to consumers.

Dr. Benner added: “We believe that notifying consumers of these realities in advance of purchase is especially urgent given that wearing glasses with the improper correction or fit can lead to additional health concerns such as dizziness and nausea. Currently, online retailers have no real obligation to ensure that the glasses purchased fit or address the patient’s visual needs and this should be made clear.”

The AOA is requesting meetings with the FTC to discuss the proposed rulemaking prior to the FTC issuing a final rule.

Significant burden on small business

In line with the AOA’s earlier advocacy efforts, the FTC proposals, which reference AOA input more than 50 times, do not seek to impose new mandates on doctors related to pupillary distance measurements, prescription verification or duplicative paperwork.

However, the AOA rebutted the reasoning behind the proposals by the FTC, which generated about 35 comments including from the AOA and 1-800-CONTACTS.

The FTC has said that the recordkeeping burden on prescribers would be “relatively minimal and outweighed by the benefits.” The AOA countered that the burden would indeed be significant for doctors of optometry—many of whom are small businesses by Small Business Administration (SBA) standards.

The SBA classifies practices with less than $9 million in annual receipts as a “small business.” Doctors of optometry reported $826,612 on average in gross receipts in 2021, according to AOA data. Further, nearly 92% of practices have fewer than 25 employees. Optometry practices also are dealing with historic staffing challenges and supply chain constraints that impact the cost of providing patient care. AOA members have reported a 12% increase in overhead costs since March 2020—when the World Health Organization declared COVID-19 a pandemic.

“These Rule changes, if finalized, would add a significant burden to small-business optometric practices that already are enduring financial challenges and staffing issues,” Dr. Benner commented.

Further, while the FTC has questioned if there are other ways to increase patient understanding of their right to their prescription under the rule, the AOA argued that “the American public already recognizes they have a right to obtain their prescription and to shop at their retailer of their choice.” For evidence of their savviness, the AOA cites growth in the online eyeglass retail market.

According to one report, an estimated 12.4 million Americans purchased glasses online in 2021.

“While different groups analyze the market in varying ways, each is showing significant growth in the use of the internet to comparison shop and to ultimately purchase eyeglasses,” Dr. Benner said.

While acknowledging FTC concerns related to compliance with the current prescription release requirement, the AOA said it was “aware that fewer than 50 prescribers have been warned’’ related to violations of the Eyeglass Rule.

“We understand that the FTC believes that implementing a signed confirmation form will enable the FTC to better monitor compliance and enforce the Rule, but this requirement seems to put the solution ahead of any real confirmation of whether a compliance issue exists,” Dr. Benner said. “The lack of data on compliance coupled with the drastic shifts in the eyeglass market in recent years as well as the ongoing public outreach regarding online eyeglass retail options calls into question whether there is any real need for additional regulations to be placed on small-business optometry practices across the country.”

Independent analysis

Among the comments submitted to the FTC was an analysis by Andrew Stivers, Ph.D. Stivers is associate director in the antitrust practice of NERA Economic Consulting and formerly deputy director for consumer protection in the FTC’s Bureau of Economics. He also served at the Food and Drug Administration overseeing public health information and data projects for the food program.

In his analysis, Stivers says that the standard for evaluating fairness to consumers under the Eyeglass Rule has changed, because of the evolution of the eyeglass marketplace.

Under the Eyeglass Rule, the FTC deems it an “unfair practice” if a doctor of optometry or ophthalmologist fails to provide a patient with a copy of their prescription after an eye examination (so a patient can comparison shop). When the rule was first adopted in the 1970s, Stivers points out, market conditions were decidedly different. Mass merchandisers and the internet had yet to transform the shopping experience for consumers, he observes. Consumers are now more empowered due to the internet; the marketplace is more competitive.

“Today, consumers can choose where to shop before getting an exam, which increases incentives to provide information and increases competition in ways that the Commission of 1978 could not imagine,” says Stivers, who raises the issue of harm to consumers today.

Stivers also questions FTC assumptions—that rule violations remain prevalent and that millions of consumers are still at risk of harm—for being dated, anecdotal and/or unsubstantiated by evidence.

“By contrast, today neither the regulatory nor the technological restrictions that predicated the determination of unfair practices still exists,” Stivers says. “The rise of new retail channels, and reductions in the market shares of the dominant retail channel relative to when that determination was made, provide further evidence that the conditions underlying a determination of unfair practices in retailing eyeglasses, and thus any benefits from increased regulatory requirements, cannot be presumed.

“Without such benefits, the rationale for technical compliance with the Eyeglass Rule’s specific conditions reduces a matter of administrative convenience and cannot be supported by an unfairness analysis,” he says. “That is, there is no relevant determination of unfairness associated with the proposed documentation requirements, and therefore no evidence or record that the documentation, or any effects on an underlying compliance issue, will have substantial benefits on consumers that would justify amending the Eyeglass Rule.”

Advocating for optometry and patient safety

The AOA is an advocacy force in Washington, D.C., ensuring that optometry is recognized and heeded on health care policy and other issues impacting practices, patients and public health. AOA doctors and students as well as its professional advocacy team are at the center of a 24/7/365 presence in the nation’s capital. Here are three ways to help ensure that illegal contact lens sellers are held accountable and adverse patient outcomes are reported:

  • Report a website illegally selling contact lenses.
  • Report an adverse event related to contact lenses.
  • Email a de-identified case report to StopIllegalCLs@aoa.org to help bolster AOA advocacy against harmful contact lens practices. Include the state where you practice in your email.
Tags: AOAEyeglass RuleFederal Trade Commission’sFTCOphthalmic Practice Rules

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
admin

admin

Related Posts

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor
Artificial Intellegance

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

by admin
April 7, 2026
0

With CBER director Vinay Prasad set to depart the agency at the end of the month, a coalition of patient...

Read moreDetails

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality

Validated Mechanisms, Strong Data Beat Hype in Longevity Investing

HHS Denies Disbandment of CDC Vaccine Advisory Group in Wake of Court Ruling

J&J Plans $1B Investment in PA Cell Therapy Manufacturing Facility

Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand

Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’

Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have to Wait

HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs

Stay Connected

  • 23.9k Followers
  • Trending
  • Comments
  • Latest
AOA makes robust rebuttal to FTC over proposed changes to Eyeglass Rule

AOA makes robust rebuttal to FTC over proposed changes to Eyeglass Rule

March 21, 2023
Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

September 15, 2024
“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

October 26, 2023
GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

February 6, 2024
AOA makes robust rebuttal to FTC over proposed changes to Eyeglass Rule

AOA makes robust rebuttal to FTC over proposed changes to Eyeglass Rule

0
Stratasys enhances digital anatomy 3D printer to bring ultra-realistic simulation and realism to functional bone models

Stratasys enhances digital anatomy 3D printer to bring ultra-realistic simulation and realism to functional bone models

0
The future of healthcare: new technologies, IoT & more

The future of healthcare: new technologies, IoT & more

0
Antihistamines

Antihistamines could improve efficacy of checkpoint inhibitors

0
Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

April 7, 2026
J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

March 23, 2026
Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality

Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality

March 23, 2026
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing

Validated Mechanisms, Strong Data Beat Hype in Longevity Investing

March 23, 2026

Recent News

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

April 7, 2026
J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

March 23, 2026
Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality

Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality

March 23, 2026
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing

Validated Mechanisms, Strong Data Beat Hype in Longevity Investing

March 23, 2026

Arab Health World

This magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.

Recent News

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor

April 7, 2026
J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales

March 23, 2026

Follow Us

  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact

© 2023 - ArabHealthWorld all rights reserved

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit

© 2023 - ArabHealthWorld all rights reserved